Dafeng Chu

1.5k total citations
16 papers, 1.3k citations indexed

About

Dafeng Chu is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Dafeng Chu has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Biomaterials. Recurrent topics in Dafeng Chu's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immune cells in cancer (4 papers). Dafeng Chu is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immune cells in cancer (4 papers). Dafeng Chu collaborates with scholars based in China, United States and Canada. Dafeng Chu's co-authors include Zhenjia Wang, Xinyue Dong, Jin Gao, Can Yang Zhang, Xutong Shi, Qi Zhao, Jingkai Gu, Faya Zhang, Hui Zhang and Jian Yu and has published in prestigious journals such as Advanced Materials, ACS Nano and Journal of Controlled Release.

In The Last Decade

Dafeng Chu

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dafeng Chu China 13 717 534 442 403 108 16 1.3k
Zhaohan Wei China 15 706 1.0× 526 1.0× 426 1.0× 283 0.7× 131 1.2× 23 1.3k
Yi‐Yin Tai United States 8 889 1.2× 725 1.4× 397 0.9× 530 1.3× 126 1.2× 16 1.5k
Adam Yuh Lin United States 15 454 0.6× 377 0.7× 320 0.7× 238 0.6× 165 1.5× 39 988
Yudi Xu China 15 583 0.8× 380 0.7× 513 1.2× 291 0.7× 97 0.9× 35 1.1k
Xianya Qin China 17 524 0.7× 347 0.6× 291 0.7× 211 0.5× 114 1.1× 23 878
Ashish Kulkarni United States 24 702 1.0× 674 1.3× 696 1.6× 275 0.7× 100 0.9× 56 1.7k
Guanghao Wu China 16 670 0.9× 764 1.4× 413 0.9× 180 0.4× 167 1.5× 43 1.4k
Danni Ran China 15 759 1.1× 715 1.3× 140 0.3× 641 1.6× 114 1.1× 16 1.4k
Lorena Simón‐Gracia Estonia 19 322 0.4× 630 1.2× 301 0.7× 380 0.9× 67 0.6× 36 1.2k
Shiyan Dong China 20 359 0.5× 744 1.4× 182 0.4× 360 0.9× 75 0.7× 34 1.3k

Countries citing papers authored by Dafeng Chu

Since Specialization
Citations

This map shows the geographic impact of Dafeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafeng Chu more than expected).

Fields of papers citing papers by Dafeng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dafeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafeng Chu. The network helps show where Dafeng Chu may publish in the future.

Co-authorship network of co-authors of Dafeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Dafeng Chu. A scholar is included among the top collaborators of Dafeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dafeng Chu. Dafeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Huang, Shigao, Fuqiang Xing, Yeneng Dai, et al.. (2023). Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment. Journal of Controlled Release. 362. 524–535. 9 indexed citations
2.
Chu, Dafeng, Xinyue Dong, Xutong Shi, Can Yang Zhang, & Zhenjia Wang. (2018). Neutrophil‐Based Drug Delivery Systems. Advanced Materials. 30(22). e1706245–e1706245. 315 indexed citations
3.
4.
Dong, Xinyue, Dafeng Chu, & Zhenjia Wang. (2017). Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites. Theranostics. 7(3). 751–763. 117 indexed citations
5.
Dong, Xinyue, Dafeng Chu, & Zhenjia Wang. (2017). Neutrophil-mediated Delivery of Nanotherapeutics Across Blood Vessel Barrier. Therapeutic Delivery. 9(1). 29–35. 19 indexed citations
6.
Chu, Dafeng, Xinyue Dong, Qi Zhao, Jingkai Gu, & Zhenjia Wang. (2017). Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration. Advanced Materials. 29(27). 158 indexed citations
7.
Gao, Jin, Dafeng Chu, & Zhenjia Wang. (2016). Cell membrane-formed nanovesicles for disease-targeted delivery. Journal of Controlled Release. 224. 208–216. 153 indexed citations
8.
Chu, Dafeng, Qi Zhao, Jian Yu, et al.. (2016). Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy. Advanced Healthcare Materials. 5(9). 1088–1093. 117 indexed citations
9.
Ran, Pan, Wen Xu, Feng Yuan, et al.. (2015). A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo. Acta Biomaterialia. 21. 74–84. 19 indexed citations
10.
Chu, Dafeng, Jin Gao, & Zhenjia Wang. (2015). Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection. ACS Nano. 9(12). 11800–11811. 227 indexed citations
11.
12.
Cao, Juan, et al.. (2015). Real-Time News Cer tification System on Sina Weibo. 983–988. 27 indexed citations
13.
Lu, Sheng, William F. Bennett, Yong Ding, et al.. (2015). Design and Characterization of a Multifunctional pH‐Triggered Peptide C8 for Selective Anticancer Activity. Advanced Healthcare Materials. 4(17). 2709–2718. 26 indexed citations
14.
Xu, Wen, Mousa Jafari, Feng Yuan, et al.. (2014). In vitro and in vivo therapeutic siRNA delivery induced by a tryptophan-rich endosomolytic peptide. Journal of Materials Chemistry B. 2(36). 6010–6010. 10 indexed citations
15.
Chu, Dafeng, et al.. (2014). Rational modification of oligoarginine for highly efficient siRNA delivery: structure–activity relationship and mechanism of intracellular trafficking of siRNA. Nanomedicine Nanotechnology Biology and Medicine. 11(2). 435–446. 31 indexed citations
16.
Xu, Wen, Pan Ran, Danyang Zhao, et al.. (2014). Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for siRNA Delivery. Molecular Pharmaceutics. 12(1). 56–65. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaohan Wei Breakdown of academic impact, for papers by Yi‐Yin Tai Breakdown of academic impact, for papers by Adam Yuh Lin Breakdown of academic impact, for papers by Yudi Xu Breakdown of academic impact, for papers by Xianya Qin Breakdown of academic impact, for papers by Ashish Kulkarni Breakdown of academic impact, for papers by Guanghao Wu Breakdown of academic impact, for papers by Danni Ran Breakdown of academic impact, for papers by Lorena Simón‐Gracia Breakdown of academic impact, for papers by Shiyan Dong
Rankless by CCL
2026